DRKS00016700招募中未知
(1-3)-beta-D-glucan ans mannan guided early termination of antifungal therapy in ICU patients - REDUCE-AM
niklinik ErlangenMikrobiologisches Institut0 个研究点目标入组 160 人开始时间: 2019年9月19日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 160
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 99 Years（—）
- 性别
- All
入选标准
- •The trial includes patients receiving antimycotic therapy (orally or i.v.) during the intensive care unit (ICU) stay, or during the 24 h preceding the transfer to the ICU without having been diagnosed with an invasive fungal infection.
排除标准
- •1. Proven invasive fungal infection
- •2. Age < 18 years
- •3. Pregnancy or breast-feeding person
- •4. Neutropenia/leukopenia
- •5. Prophylactic intake of antimycotics
- •6. BDG and mannan testing during the past 7 days
- •7. Moribund Patient
- •8. Participation in another intervention trial.
研究者
相似试验
尚未招募
Unknown
sefulness of Beta-D Glucan (BDG) test in the treatment of fungal diseases in intensive care setupCTRI/2023/07/055921Apollo Hospitals
已完成
不适用
Evaluation of (1->3)-Beta-D-Glucan as a Diagnostic Tool for HIV associated Pneumocystis PneumoniaJPRN-UMIN000014818ational Center for Global Health and Medicine180
尚未招募
Unknown
diagnosis of invasive fungal infectionsCTRI/2023/07/055119Max Super Speciality Hospital
终止
不适用
The potential of beta-glucan intake in the prevention of viral diseases.influenza and norovirus-related gastroenteritisJPRN-UMIN000020660Kochi University80
Unknown
2 期
Development The Potentiality of β-1,3/1,6-D-Glucan (Polysaccharide Peptide) From Mycelia Extract of Indonesia's Ganoderma Lucidum as Adjuvant Therapy in Patients With Cardiometabolic SyndromeCardiometabolic SyndromeNCT05079529University of Brawijaya70